Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec Earns Bayer Milestone Under Multi-Target Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Evotec Earns Bayer Milestone Under Multi-Target Alliance

Transitions molecule into preclinical development for the treatment of endometriosis

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evotec’s multi-target collaboration with Bayer HealthCare has reached an important milestone, transitioning an undisclosed molecule into preclinical development for the treatment of endometriosis. Financial details were not disclosed.
 
Under the October 2012 agreement, the companies aim to develop three clinical candidates within a five-year term. Both parties contribute drug targets and technology infrastructures and share the responsibility for early research and preclinical characterization of potential candidates to treat endometriosis.
 
Dr. Mario Polywka, chief operating officer of Evotec, said, “We are very pleased to achieve this validation of our joint work with the Bayer team. Both teams of scientists have developed a tremendous relationship and collaborative way of working and we look forward to continue this productive work and focus our efforts on bringing forward new drug candidates to tackle this significant disease.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics